142 related articles for article (PubMed ID: 34271191)
21. Chronic granulomatous disease: diagnosis and classification at the molecular level.
Hopkins PJ; Bemiller LS; Curnutte JT
Clin Lab Med; 1992 Jun; 12(2):277-304. PubMed ID: 1611821
[TBL] [Abstract][Full Text] [Related]
22. Atypical familial Papillon-Lefèvre syndrome.
Inalöz HS; Harman M; Akdeniz S; Inalöz SS; Isik AG
J Eur Acad Dermatol Venereol; 2001 Jan; 15(1):48-50. PubMed ID: 11451323
[TBL] [Abstract][Full Text] [Related]
23. Pioglitazone restores phagocyte mitochondrial oxidants and bactericidal capacity in chronic granulomatous disease.
Fernandez-Boyanapalli RF; Frasch SC; Thomas SM; Malcolm KC; Nicks M; Harbeck RJ; Jakubzick CV; Nemenoff R; Henson PM; Holland SM; Bratton DL
J Allergy Clin Immunol; 2015 Feb; 135(2):517-527.e12. PubMed ID: 25498313
[TBL] [Abstract][Full Text] [Related]
24. [Recurrent European missense mutation in a Hungarian pedigree with Papillon-Lefèvre syndrome].
Vályi P; Farkas K; Tripolszki K; Sulák A; Széll M; Nagy N; Nagy K
Fogorv Sz; 2014 Sep; 107(3):87-92. PubMed ID: 25509509
[TBL] [Abstract][Full Text] [Related]
25. Papillon-Lefèvre syndrome: Oral aspects and treatment.
Giannetti L; Apponi R; Dello Diago AM; Jafferany M; Goldust M; Sadoughifar R
Dermatol Ther; 2020 May; 33(3):e13336. PubMed ID: 32222110
[TBL] [Abstract][Full Text] [Related]
26. Papillon Lefevre syndrome.
Thomas S; Gummadapu S; Ahsan A; Pai KM
Saudi Med J; 2004 Jul; 25(7):941-3. PubMed ID: 15235704
[TBL] [Abstract][Full Text] [Related]
27. Oral manifestations in 22q11 deletion syndrome.
Klingberg G; Oskarsdóttir S; Johannesson EL; Norén JG
Int J Paediatr Dent; 2002 Jan; 12(1):14-23. PubMed ID: 11853243
[TBL] [Abstract][Full Text] [Related]
28. Chronic granulomatous disease: a syndrome of phagocyte oxidase deficiencies.
Tauber AI; Borregaard N; Simons E; Wright J
Medicine (Baltimore); 1983 Sep; 62(5):286-309. PubMed ID: 6353131
[TBL] [Abstract][Full Text] [Related]
29. Immunodeficiency diseases caused by defects in phagocytes.
Lekstrom-Himes JA; Gallin JI
N Engl J Med; 2000 Dec; 343(23):1703-14. PubMed ID: 11106721
[No Abstract] [Full Text] [Related]
30. Disorders of phagocyte function.
Weston WL
Arch Dermatol; 1976 Nov; 112(11):1589-96. PubMed ID: 984866
[TBL] [Abstract][Full Text] [Related]
31. Characterization of neutrophil function in Papillon-Lefèvre syndrome.
Roberts H; White P; Dias I; McKaig S; Veeramachaneni R; Thakker N; Grant M; Chapple I
J Leukoc Biol; 2016 Aug; 100(2):433-44. PubMed ID: 26957212
[TBL] [Abstract][Full Text] [Related]
32. Congenital neutropenia and primary immunodeficiency disorders: a survey of 26 Iranian patients.
Rezaei N; Farhoudi A; Ramyar A; Pourpak Z; Aghamohammadi A; Mohammadpour B; Moin M; Gharagozlou M; Movahedi M; Ghazi BM; Izadyar M; Mahmoudi M
J Pediatr Hematol Oncol; 2005 Jul; 27(7):351-6. PubMed ID: 16012323
[TBL] [Abstract][Full Text] [Related]
33. Chronic granulomatous disease of childhood: a saga of discovery and understanding.
Quie PG
Pediatr Infect Dis J; 1993 May; 12(5):395-8. PubMed ID: 8327301
[No Abstract] [Full Text] [Related]
34. Papillon-Lefevre syndrome: a case report.
Pratchyapruit WO; Kullavanijaya P
J Dermatol; 2002 Jun; 29(6):329-35. PubMed ID: 12126066
[TBL] [Abstract][Full Text] [Related]
35. Glycosyl-phosphatidyl-inositol-defective granulocytes from paroxysmal nocturnal haemoglobinuria patients show increased bacterial ingestion but reduced respiratory burst induction.
Cacciapuoti C; Terrazzano G; Barone L; Sica M; Becchimanzi C; Rotoli B; Ruggiero G; Alfinito F
Am J Hematol; 2007 Feb; 82(2):98-107. PubMed ID: 17013814
[TBL] [Abstract][Full Text] [Related]
36. Partial expression of Papillon-Lefèvre Syndrome.
Kothiwale SV; Mathur S
Indian J Dent Res; 2008; 19(3):264-6. PubMed ID: 18797107
[TBL] [Abstract][Full Text] [Related]
37. Partial expression of the Papillon-Lefevre syndrome.
Shanavas M; Chatra L; Shenai P; Kumar S; Bilahari N; Balakrishnan S
J Coll Physicians Surg Pak; 2014 Nov; 24 Suppl 3():S230-2. PubMed ID: 25518784
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic Approach to the Patients with Suspected Primary Immunodeficiency.
Tavakol M; Jamee M; Azizi G; Sadri H; Bagheri Y; Zaki-Dizaji M; Mahdavi FS; Jadidi-Niaragh F; Tajfirooz S; Kamali AN; Aghamahdi F; Noorian S; Kojidi HT; Mosavian M; Matani R; Dolatshahi E; Porrostami K; Elahimehr N; Fatemi-Abhari M; Sharifi L; Arjmand R; Haghi S; Zainaldain H; Yazdani R; Shaghaghi M; Abolhassani H; Aghamohammadi A
Endocr Metab Immune Disord Drug Targets; 2020; 20(2):157-171. PubMed ID: 31456526
[TBL] [Abstract][Full Text] [Related]
39. Chronic granulomatous disease and other disorders of phagocyte function.
Dinauer MC
Hematology Am Soc Hematol Educ Program; 2005; ():89-95. PubMed ID: 16304364
[TBL] [Abstract][Full Text] [Related]
40. Retroviral-mediated gene transfer of gp91phox into bone marrow cells rescues defect in host defense against Aspergillus fumigatus in murine X-linked chronic granulomatous disease.
Björgvinsdóttir H; Ding C; Pech N; Gifford MA; Li LL; Dinauer MC
Blood; 1997 Jan; 89(1):41-8. PubMed ID: 8978275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
